Pulmonary embolism in chronic hypoxemic patients with and without secondary polycythemia - Analysis of risk factors in prospective clinical study;Plućni embolizam kod hronično hipoksemičnih pacijenata sa i bez sekundarne policitemije - Analiza faktora rizika u prospektivnoj kliničkoj studiji

Medicinski Glasnik

Volumn 10, Issue 2, 2013, Pages 258-265

  Ristić, Lidija ^a,b   Rančić, Milan ^a,b   Radović, Milan ^a,b   Ćirić, Zorica ^a,b   Kurtović, Dušanka Kutlešić ^b  

^a UNIVERSITY OF NI   (Serbia)

^b CLINICAL CENTER NI   (Serbia)

Author keywords

Arrhythmia; Chronic obstructive pulmonary disease; Multidetector computed tomography; Pulmonary hypertension; Varicose veins

Indexed keywords

D DIMER;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLOR ULTRASOUND FLOWMETRY; COR PULMONALE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTOSIS; FEMALE; GAS ANALYSIS; HEART ARRHYTHMIA; HUMAN; HYPERCAPNIA; HYPOXEMIA; LUNG EMBOLISM; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RISK FACTOR; VARICOSIS; POLYCYTHEMIA; PULMONARY EMBOLISM;

HUMANS; POLYCYTHEMIA; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM; RISK FACTORS;

EID: 84880735849     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lopez AD, Shibuya K, Rao C, Mathes CD, Hansell LB, Helad LS, Schmid B, Buist S. Chronic obstructive lung disease-current burden and future projections. Eur Resp J 2006; 27:397-412.
2. Global strategy for diagnosis, management, and prevention of COPD. 2011. http//www.goldcopd.org (March 7, 2012).
3. Kent DB, Mitchell DP, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011; 6:199-208.
4. Pierson DJ. Pathophysiology and Clinical Effects of Chronic Hypoxia Respir Care 2000; 45:39-51.
5. Vaidyula VR, Criner GJ, Grabianowski C, Rao AK. Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease. Thromb Res 2009; 124:259-61.
6. Coglianese EE, Qureshi MM, Vasan RS, Wang TJ, Moore LL, Usefulness of the Blood Hematocrit Level to Predict Development of Heart Failure in a Community. AJC 2012; 109:241-5.
7. Chambellan A, Chailleux E, Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005; 128:1201-8.
8. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007; 29:923-9.
9. Vlahakos DV, Kosmas EN, Dimopoulou I, Ikonomou E, Jullien G, Vassilakos P, Marathias KP. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary diseases. AJM 1999; 106:158-64.
10. Shetty R, Seddughzadeh A, Piazza G, Goldhaber SZ. Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. J Thromb Thrombolysis 2008; 26:35-40.
11. Stein PD, Beemath A, Meyers FA, Olson RE. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease. J Cardiovasc Med 2007; 8:253-7.
12. Monreal M, Munoz-Torrero JF, Naraine VS, Jiménez D, Soler S, Rabuñal R, Gallego P; RIETE Investigators. Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure. Am J Med 2006; 119:851-8.
13. Ambrosetti M, Ageno W, Spanevello A, Spanevello A, Salerno M, Pedretti RF. Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD. Thromb Res 2003; 112:203-7.
14. Bertoletti L, Quenet S, Mismetti P, Hernandez L et RIETE investigators. Clinical presentation and outcome of venous thromboembolism in COPD. Eur Resp J 2012; 39: 862-8
15. Piazza G. Goldhaber SZ, Kroll A, Golodberg RJ, Emery C, Spencer FA. Venous thromboembolism in patients with chronic obstructive pulmonary embolism. AJM 2012; 125:1010-18.
16. Moua T, Kenneth Wood K. COPD and PE: a clinical dilemma. Int J Chron Obstruct Pulmon Dis 2008; 3:277-84.
17. Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and meta analysis. Chest 2009; 135:786-93.
18. Tilli Leblond I, Marquette CH, Perez T, Scherpereel A, Zanetti C, Tonnel AB, Remy Jardin M. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 2006; 144:390-6.
19. Rutschmann OT, Cornuz J, Poletti PA, Bridveaux PO, Hugli OW, Quandli SD, Perrier A. Should pulmonary embolism be suspected in exacerbations of chronic obstructive pulmonary disease? Thorax 2007; 62:121-5.
20. Gunen H, Gulbas G, In E Yetkin O, Hacievliyagil SS. Venous thromboembolism and exacerbations of COPD. Eur Respir J 2010; 35:1243-8.
21. Spencer AF, Emery C, Lessard D, Anderson F, Emani S, Aragam J, Becker CR, Robert J Goldberg JR. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006; 2:722-7.
22. Stein PD, Hull RD, Patel KC, Olson RK, Ghall WA, Brant R, Biel RK, Bharadin V, Kaira NK. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 2004; 140:589-602.
23. Akgun M, Meral M, Onbas O, Araz O, Kaplay M, Alan S Mirici A. Comparison of clinical characteristics and outcomes of patients with COPD exacerbation with or without venous thromboembolism. Respiration 2006; 73:428-33.
24. Legnani C, Cini M, Cosmi B, Legnani C, Tosetto A, Pengo V. Different cut-off values of quantitative Ddimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. Haematologica 2008; 93:900-7.
25. Legnani C, Cini M, Cosmi B, Carraro P, Tripodi A, Erba N, Palareti G. Age and gender specific cutoff values to improve the performance of D-dimer assays to predict the risk of veonous thromboembolism recurrence. Intern Emerg Med 2013; 8:229-36.